Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity.
Journal: Nature communications
Published: March 24, 2025
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Journal: Science translational medicine
Published: February 08, 2023
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Journal: Life science alliance
Published: January 08, 2023
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
Journal: Nature communications
Published: February 08, 2021
BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice.
Journal: Vaccines
Published: November 20, 2020
KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.
Journal: Frontiers in immunology
Published: June 26, 2018
A Plasmodium Cross-Stage Antigen Contributes to the Development of Experimental Cerebral Malaria.
Journal: Frontiers in immunology
Published: May 12, 2018
Transmission of the malaria parasite requires ferlin for gamete egress from the red blood cell.
Journal: Cellular microbiology
Published: May 11, 2018
Varying Immunizations With Plasmodium Radiation-Attenuated Sporozoites Alter Tissue-Specific CD8+ T Cell Dynamics.
Journal: Frontiers in immunology
Published: March 03, 2018
Plasmodium attenuation: connecting the dots between early immune responses and malaria disease severity.
Journal: Frontiers in microbiology
Published: September 30, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026